PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
and future commercialization of its nPulse Cardiac Catheter Ablation System. The initiative follows highly breakthrough clinical results from the company's 150-patient European feasibility study, which showcased the strong potential of its proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology in treating Atrial Fibrillation (AFib). Per management, data from more than 150 patients in Europe delivers a strong and conclusive signal, showing that the nPulse system has clear potential to transform clinical practice and improve treatment outcomes for millions. Advancing this program is a top priority, with capital allocation being adjusted to fully support the opportunity. Paul LaViolette, CEO and Co-Chairman, added that the company is excited to dedicate additional resources to its catheter-based electrophysiology (EP) program, strengthening an initiative that has already demonstrated the potential to be both first-in-class and best-in-class. Likely Trend of PLSE Stock Foll
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical DataBusiness Wire
- Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]Yahoo! Finance
- A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]Yahoo! Finance
PLSE
Earnings
- 2/19/26 - Beat
PLSE
Sec Filings
- 3/27/26 - Form 8-K
- 3/17/26 - Form 8-K
- 3/12/26 - Form 8-K
- PLSE's page on the SEC website